SCHOTT Pharma AG & Co. KGaA/ADR STTPF

The SEC does not publish structured financial data (XBRL) for SCHOTT Pharma AG & Co. KGaA/ADR, so there are no statement tables here. This is common for foreign companies that trade over the counter and for filers that only submit documents. Its filings are still listed below and on SEC EDGAR.

Recent SEC filings

Recent SEC filings
Form Description Filed Period
F-6EF Filing Oct 22, 2026 —
F-6EF Filing Apr 24, 2024 —
F-6EF Filing Apr 9, 2024 —

Company profile

Listed as
SHTPY (OTC), STTPF (OTC)
Fiscal year ends
September 30
Incorporated in
Germany
Headquarters
New York, NY
SEC CIK
2018852

Source: SEC EDGAR filings. This is company-reported data, not investment advice.